Background illustration for clinical trials search

Paid Clinical Trials ​Thousand Oaks

Discover 3,032 paid clinical trials in ​Thousand Oaks, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Phase II Study in Patients With Moderate to Severe ARDS Due to COVID-19

for
Covid19
Location: Santa Monica CA, Fullerton CA
Sponsor: Stemedica Cell Technologies, Inc.

Sex: All

Age: 18+

Code: NCT04780685

Phase2, Recruiting

A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

for
Metastatic Castration-Resistant Prostate Cancer (mCRPC),
Location: Santa Monica CA, Phoenix AZ, Gilbert AZ, Tucson AZ,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT03972657

Phase1, Phase2, Recruiting

TR(ACE) Assay Clinical Specimen Study

for
Carcinoma, Non-Small-Cell Lung, Breast Neoplasms
Location: Santa Monica CA, Oceanside CA, Encinitas CA, Tyler TX,
Sponsor: Biological Dynamics

Sex: All

Age: 21+

Code: NCT02934360

Recruiting

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

for
Breast Cancer
Location: Santa Monica CA, Whittier CA, Duarte CA, Fullerton CA,
Sponsor: Greenwich LifeSciences, Inc.

Sex: All

Age: 18 - 70+

Code: NCT05232916

Phase3, Recruiting

A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer

for
Advanced Breast Cancer
Location: Santa Monica CA, Duarte CA, La Jolla CA, Palo Alto CA,
Sponsor: Stemline Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06638307

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
New

A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH

for
Narcolepsy, Idiopathic Hypersomnia
Location: Los Angeles CA, Cincinnati OH, Dublin OH
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07625280

Phase3, Recruiting

A Study of Pitolisant in Patients With Prader-Willi Syndrome

for
Prader-Willi Syndrome
Location: Los Angeles CA, San Diego CA, Sacramento CA, Aurora CO,
Sponsor: Harmony Biosciences Management, Inc.

Sex: All

Age: 6+

Code: NCT06366464

Phase3, Recruiting

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

for
Breast Cancer, Locally Advanced Breast Cancer,
Location: Beverly Hills CA, Los Alamitos CA, La Jolla CA,
Sponsor: Olema Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT07085767

Phase3, Recruiting

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

for
Metastatic Colorectal Cancer (CRC)
Location: Los Angeles CA, Beverly Hills CA, West Hollywood CA,
Sponsor: Summit Therapeutics

Sex: All

Age: 18+

Code: NCT07228832

Phase3, Recruiting

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

for
Cardiotoxicity, HER2/Neu Positive,
Location: Mission Hills CA, Torrance CA, Los Angeles CA,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT03418961

Phase3, Recruiting

Reduction of C-Difficile Infection Using Stool Transplant

for
C-difficile
Location: Mission Hills CA
Sponsor: Providence Holy Cross Medical Center

Sex: All

Age: 18+

Code: NCT02112279

Phase1, Recruiting

A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis

for
Myasthenia Gravis, Generalized
Location: Mission Hills CA, Las Vegas NV, Sherman TX,
Sponsor: Vertex Pharmaceuticals Incorporated

Sex: All

Age: 18+

Code: NCT07501702

Phase2, Recruiting

BBO-11818 in Adult Subjects With KRAS Mutant Cancer

for
Non-Small Cell Lung Cancer, NSCLC,
Location: Los Angeles CA, San Diego CA, San Francisco CA,
Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)

Sex: All

Age: 18+

Code: NCT06917079

Phase1, Recruiting

A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors

for
Solid Tumors, Advanced Solid Tumors, Metastatic Solid Tumors
Location: Los Angeles CA, San Antonio TX, Houston TX,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT05836324

Phase1, Recruiting

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

for
Metastatic Uveal Melanoma
Location: Los Angeles CA, La Jolla CA, Palo Alto CA,
Sponsor: Replimune Inc.

Sex: All

Age: 0+

Code: NCT06581406

Phase2, Phase3, Recruiting

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

for
Tumor Skin, Metastatic Melanoma, Melanoma, Lung Cancer,
Location: Los Angeles CA, Stanford CA, Houston TX, Louisville KY,
Sponsor: Obsidian Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06060613

Phase1, Phase2, Recruiting

SNV4818 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Los Angeles CA, Houston TX, Nashville TN, Toronto,
Sponsor: Pikavation Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06736704

Phase1, Phase2, Recruiting

Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors

for
Melanoma Stage IV, Solid Tumor
Location: Los Angeles CA, Fullerton CA, Bakersfield CA,
Sponsor: Georgiamune Inc

Sex: All

Age: 18+

Code: NCT06425926

Phase1, Phase2, Recruiting

Safety and Tolerability Study of GIM-122 in Subjects With Advanced Solid Malignancies

for
Advanced Solid Malignancies
Location: Los Angeles CA, San Francisco CA, Irving TX, Dallas TX,
Sponsor: Georgiamune Inc

Sex: All

Age: 18+

Code: NCT06028074

Phase1, Phase2, Recruiting

Study of TBX-3400 in Patients With Stage III and IV Melanoma Resistant or Refractory to Immune Checkpoint Inhibitors

for
Stage III Melanoma, Stage IV Melanoma
Location: Los Angeles CA, Denver CO
Sponsor: Taiga Biotechnologies, Inc.

Sex: All

Age: 18+

Code: NCT03385486

Phase1, Recruiting